Exodos Life Sciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Exodos Life Sciences General Information

Description

Operator of a pharmaceutical development company intended to focus on advancing innovative drug concepts. The company concentrates on applied therapy directed towards safe and effective topically delivered medications for the treatment of different human conditions including pain and inflammation, enabling healthcare professionals to precisely tailor medication project needs with the right level of pharmaceutical expertise.

Contact Information

Website
www.exodosls.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6340 Quadrangle Drive
  • Suite 120
  • Chapel Hill, NC 27517
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 6340 Quadrangle Drive
  • Suite 120
  • Chapel Hill, NC 27517
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exodos Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 10-Mar-2023 Completed Out of Business
2. Later Stage VC (Series A1) 12-Mar-2014 Completed Generating Revenue
1. Seed Round 30-Nov-2011 $1.76M $1.76M Completed Startup
To view Exodos Life Sciences’s complete valuation and funding history, request access »

Exodos Life Sciences Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Exodos Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2998895-A1 Topical antifungal compositions Inactive 07-Oct-2015
EP-3359133-A1 Topical antifungal compositions Active 07-Oct-2015
EP-3359133-A4 Topical antifungal compositions Active 07-Oct-2015
EP-3359133-B1 Topical antifungal compositions Active 07-Oct-2015
US-10272054-B2 Topical antifungal compositions Active 07-Oct-2015 A61K31/137
To view Exodos Life Sciences’s complete patent history, request access »

Ready to get started?

Request a free trial

Exodos Life Sciences FAQs

  • When was Exodos Life Sciences founded?

    Exodos Life Sciences was founded in 2009.

  • Where is Exodos Life Sciences headquartered?

    Exodos Life Sciences is headquartered in Chapel Hill, NC.

  • What industry is Exodos Life Sciences in?

    Exodos Life Sciences’s primary industry is Pharmaceuticals.

  • Is Exodos Life Sciences a private or public company?

    Exodos Life Sciences is a Private company.

  • What is Exodos Life Sciences’s current revenue?

    The current revenue for Exodos Life Sciences is .

  • How much funding has Exodos Life Sciences raised over time?

    Exodos Life Sciences has raised $2.45M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process